Maqola

THE EFFECTIVENESS OF ULINASTATIN IN PATIENTS WITH CHRONIC PANCREATITIS

M. Sh. KarimovDoctor of Medical Sciences, Professor. Head of the Department of Gastroenterology of the Republican Specialized Scientific and Practical Medical Center for Therapy and Medical Rehabilitation, Tashkent, UzbekistanSobirova, G.Doctor of Medical Sciences, Senior researcher. Professor of Rehabilitation, Folk Medicine and Physical Education Department of the Tashkent Medical Academy, Tashkent, UzbekistanJ. IsmailovaDoctor of Medical Sciences, Gastroenterologist of Department of Gastroenterology of the Republican Specialized Scientific and Practical Medical Center for Therapy and Medical Rehabilitation, Tashkent, Uzbekistan

Zenodo (CERN European Organization for Nuclear Research)repository2022en

ABI

Annotatsiya

<strong>Abstract</strong> The article presents the results of the anti-inflammatory efficacy of the new generation protease inhibitor ulinastatin in the treatment of exacerbation of chronic pancreatitis of moderate severity. It is shown that exacerbation of chronic pancreatitis of alimentary, alcoholic and biliary etiology was expressed by abdominal pain and dyspeptic symptoms. An increase in the level of serum aminotransferases, bilirubin and alpha amylase was noted, which was accompanied by a significant increase in the activity of pro-inflammatory cytokines. The use of ulinastatin in the complex of pharmacotherapy of chronic pancreatitis contributed to the effective relief of exacerbation of pancreatitis, which was due to the anticytokine effect of the drug.

Hali tarjima qilinmagan

Mavzular

Pancreatitis Pathology and Treatment Intestinal and Peritoneal Adhesions Intraperitoneal and Appendiceal Malignancies

Identifikatorlar

DOI: 10.5281/zenodo.7258674

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar · Tez orada